Transanal Irrigation for Anterior Resection Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether transanal irrigation (TAI), a method to manage bowel movements, can improve quality of life for individuals with low anterior resection syndrome (LARS) after bowel surgery. The study examines if TAI aids in bowel control and reduces urgent bathroom trips within the first year post-surgery. Participants include patients who have undergone specific bowel surgery and are preparing for an ileostomy closure within 12 months. As an unphased study, this trial provides patients the chance to contribute to research that may enhance post-surgical recovery and quality of life.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that transanal irrigation is safe for patients with low anterior resection syndrome?
Research has shown that transanal irrigation (TAI) is generally easy for patients to use. Studies have found that TAI can help people with low anterior resection syndrome (LARS) feel better over the long term. In these studies, patients reported high satisfaction and experienced significant symptom relief for several years. This suggests that TAI is safe and might improve quality of life by making bowel movements more predictable and reducing urgency. Although large clinical trials are not yet available, current evidence supports its safety and effectiveness for managing LARS symptoms.12345
Why are researchers excited about this trial?
Researchers are excited about transanal irrigation (TAI) for anterior resection syndrome because it offers a new approach that goes beyond the usual conservative management options. Unlike standard treatments that often involve dietary changes, medications, and pelvic floor exercises, TAI uses a specialized irrigation kit to directly flush out the lower bowel. This method can provide more immediate and controlled relief from symptoms. Additionally, the integration of the LARS app, which supports patients in managing their condition, enhances the potential for personalized and effective treatment.
What evidence suggests that transanal irrigation is effective for anterior resection syndrome?
Research has shown that transanal irrigation (TAI), which participants in the TAI-intervention arm of this trial will receive, can greatly help people with low anterior resection syndrome (LARS). One study found that patients using TAI had much lower LARS scores upon hospital discharge, indicating significant symptom improvement. Another study identified TAI as one of the most effective treatments for severe LARS, with noticeable short-term improvements. Patients have reported better control over bowel movements and an improved quality of life. Overall, TAI appears to be a promising method for managing bowel function after surgery.23467
Are You a Good Fit for This Trial?
This trial is for individuals who have undergone surgery for colorectal cancer and are experiencing early Low Anterior Resection Syndrome (LARS), which affects bowel control. Participants should be in the 1-12 months post-operative period.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Transanal Irrigation (TAI) or continue with conservative management for LARS
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Transanal Irrigation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Case Comprehensive Cancer Center
Lead Sponsor